BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12689820)

  • 1. Function, subcellular localization and assembly of a novel mutation of KCNJ2 in Andersen's syndrome.
    Hosaka Y; Hanawa H; Washizuka T; Chinushi M; Yamashita F; Yoshida T; Komura S; Watanabe H; Aizawa Y
    J Mol Cell Cardiol; 2003 Apr; 35(4):409-15. PubMed ID: 12689820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Andersen mutations of KCNJ2 suppress the native inward rectifier current IK1 in a dominant-negative fashion.
    Lange PS; Er F; Gassanov N; Hoppe UC
    Cardiovasc Res; 2003 Aug; 59(2):321-7. PubMed ID: 12909315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo and in vitro functional characterization of Andersen's syndrome mutations.
    Bendahhou S; Fournier E; Sternberg D; Bassez G; Furby A; Sereni C; Donaldson MR; Larroque MM; Fontaine B; Barhanin J
    J Physiol; 2005 Jun; 565(Pt 3):731-41. PubMed ID: 15831539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel KCNJ2 nonsense mutation, S369X, impedes trafficking and causes a limited form of Andersen-Tawil syndrome.
    Doi T; Makiyama T; Morimoto T; Haruna Y; Tsuji K; Ohno S; Akao M; Takahashi Y; Kimura T; Horie M
    Circ Cardiovasc Genet; 2011 Jun; 4(3):253-60. PubMed ID: 21493816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biophysical and molecular characterization of a novel de novo KCNJ2 mutation associated with Andersen-Tawil syndrome and catecholaminergic polymorphic ventricular tachycardia mimicry.
    Barajas-Martinez H; Hu D; Ontiveros G; Caceres G; Desai M; Burashnikov E; Scaglione J; Antzelevitch C
    Circ Cardiovasc Genet; 2011 Feb; 4(1):51-7. PubMed ID: 21148745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and functional characterisation of a novel KCNJ2 mutation, Val302del, causing Andersen-Tawil syndrome.
    Ördög B; Hategan L; Kovács M; Seprényi G; Kohajda Z; Nagy I; Hegedűs Z; Környei L; Jost N; Katona M; Szekeres M; Forster T; Papp JG; Varró A; Sepp R
    Can J Physiol Pharmacol; 2015 Jul; 93(7):569-75. PubMed ID: 26103554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss-of-function mutations of the K(+) channel gene KCNJ2 constitute a rare cause of long QT syndrome.
    Fodstad H; Swan H; Auberson M; Gautschi I; Loffing J; Schild L; Kontula K
    J Mol Cell Cardiol; 2004 Aug; 37(2):593-602. PubMed ID: 15276028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KCNJ2 mutation causes an adrenergic-dependent rectification abnormality with calcium sensitivity and ventricular arrhythmia.
    Kalscheur MM; Vaidyanathan R; Orland KM; Abozeid S; Fabry N; Maginot KR; January CT; Makielski JC; Eckhardt LL
    Heart Rhythm; 2014 May; 11(5):885-94. PubMed ID: 24561538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Andersen's syndrome mutants produce a knockdown of inwardly rectifying K
    Simkin D; Robin G; Giuliano S; Vukolic A; Moceri P; Guy N; Wagner KD; Lacampagne A; Allard B; Bendahhou S
    Cell Tissue Res; 2018 Feb; 371(2):309-323. PubMed ID: 29018970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trafficking-competent and trafficking-defective KCNJ2 mutations in Andersen syndrome.
    Ballester LY; Benson DW; Wong B; Law IH; Mathews KD; Vanoye CG; George AL
    Hum Mutat; 2006 Apr; 27(4):388. PubMed ID: 16541386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T75M-KCNJ2 mutation causing Andersen-Tawil syndrome enhances inward rectification by changing Mg2+ sensitivity.
    Tani Y; Miura D; Kurokawa J; Nakamura K; Ouchida M; Shimizu K; Ohe T; Furukawa T
    J Mol Cell Cardiol; 2007 Aug; 43(2):187-96. PubMed ID: 17582433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotype-phenotype correlations of KCNJ2 mutations in Japanese patients with Andersen-Tawil syndrome.
    Haruna Y; Kobori A; Makiyama T; Yoshida H; Akao M; Doi T; Tsuji K; Ono S; Nishio Y; Shimizu W; Inoue T; Murakami T; Tsuboi N; Yamanouchi H; Ushinohama H; Nakamura Y; Yoshinaga M; Horigome H; Aizawa Y; Kita T; Horie M
    Hum Mutat; 2007 Feb; 28(2):208. PubMed ID: 17221872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KCNJ2 mutations in arrhythmia patients referred for LQT testing: a mutation T305A with novel effect on rectification properties.
    Eckhardt LL; Farley AL; Rodriguez E; Ruwaldt K; Hammill D; Tester DJ; Ackerman MJ; Makielski JC
    Heart Rhythm; 2007 Mar; 4(3):323-9. PubMed ID: 17341397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel KCNJ2 mutation in familial periodic paralysis with ventricular dysrhythmia.
    Ai T; Fujiwara Y; Tsuji K; Otani H; Nakano S; Kubo Y; Horie M
    Circulation; 2002 Jun; 105(22):2592-4. PubMed ID: 12045162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase A-dependent biophysical phenotype for V227F-KCNJ2 mutation in catecholaminergic polymorphic ventricular tachycardia.
    Vega AL; Tester DJ; Ackerman MJ; Makielski JC
    Circ Arrhythm Electrophysiol; 2009 Oct; 2(5):540-7. PubMed ID: 19843922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KCNJ2 mutation in intractable ventricular arrhythmia with Andersen's syndrome.
    Takahashi T; Tandai S; Toki T; Sato T; Eto S; Sato A; Ueda T; Sato S; Ichinose K; Ito E; Yonesaka S
    Pediatr Int; 2005 Apr; 47(2):220-3. PubMed ID: 15852530
    [No Abstract]   [Full Text] [Related]  

  • 17. A novel gain-of-function KCNJ2 mutation associated with short-QT syndrome impairs inward rectification of Kir2.1 currents.
    Hattori T; Makiyama T; Akao M; Ehara E; Ohno S; Iguchi M; Nishio Y; Sasaki K; Itoh H; Yokode M; Kita T; Horie M; Kimura T
    Cardiovasc Res; 2012 Mar; 93(4):666-73. PubMed ID: 22155372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional and clinical characterization of a mutation in KCNJ2 associated with Andersen-Tawil syndrome.
    Lu CW; Lin JH; Rajawat YS; Jerng H; Rami TG; Sanchez X; DeFreitas G; Carabello B; DeMayo F; Kearney DL; Miller G; Li H; Pfaffinger PJ; Bowles NE; Khoury DS; Towbin JA
    J Med Genet; 2006 Aug; 43(8):653-9. PubMed ID: 16571646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a novel, dominant negative KCNJ2 mutation associated with Andersen-Tawil syndrome.
    Marrus SB; Cuculich PS; Wang W; Nerbonne JM
    Channels (Austin); 2011; 5(6):500-9. PubMed ID: 22186697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticosteroid-exacerbated symptoms in an Andersen's syndrome kindred.
    Bendahhou S; Fournier E; Gallet S; Ménard D; Larroque MM; Barhanin J
    Hum Mol Genet; 2007 Apr; 16(8):900-6. PubMed ID: 17324964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.